Clinical Trials Logo
  1. Home
  2. Hemangioma
  3. NCT01908972

The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma

Hemangioma Clinical Trial

Official title:
The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma

Clinical Trial Summary

The purpose of this study is to determine the safety and efficiency of Propranolol as an initial treatment for pediatric hemangioma.

Clinical Trial Description

- Randomized (A group : propranolol, B group : prednisolone)

- A group : 3 days admission and medication for 16 weeks

- B group : medication for 16 weeks without admission

- Hemangioma volume comparison by using MRI

- other measurement and drug adverse reaction monitoring ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01908972
Study type Interventional
Source Seoul National University Hospital
Contact
Status Completed
Phase Phase 4
Start date June 2013
Completion date May 2015
View Details
See also
  Status Clinical Trial Phase
Completed NCT01685398 - Topical Timolol for Superficial Infantile Hemangioma Phase 3
Withdrawn NCT00974129 - A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas N/A
Completed NCT00374335 - Incidence of Hepatic Hemangiomatosis in Patients With Cutaneous Hemangiomas N/A
Recruiting NCT03331744 - Clinical Characteristics of Infantile Hemangioma
Completed NCT02342275 - Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma Phase 3
Completed NCT00433940 - Immune Suppression Of Infants Treated With Steroids N/A
Completed NCT04065217 - The Effectiveness of Diode Laser 980-nm in Iraqi Face Hemangioma: a Randomized Within Patients Trial N/A
Terminated NCT01743885 - Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma Phase 3
Terminated NCT00555464 - Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas Phase 2
Completed NCT00394888 - Hemangioma Associated With High Rates of Morbidity N/A
Completed NCT05327309 - Role of Propranolol as Compared to Bleomycin in Management of Hemangioma N/A
Completed NCT02145884 - Topical Timolol Gel for the Treatment of Infantile Hemangiomas Phase 2
Completed NCT04077515 - Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma Phase 4
Completed NCT02731287 - Topical Timolol for Infantile Hemangioma in Early Proliferative Phase Phase 2
Recruiting NCT01147601 - Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas Phase 0
Completed NCT00540566 - Optical Biopsy of Human Skin in Conjunction With Laser Treatment
Completed NCT00001417 - Direct Injection of Alcohol for the Treatment of Spinal Tumors N/A
Completed NCT00004436 - Randomized Study of Hormonal Regulation of Infantile Hemangioma N/A
Recruiting NCT02496013 - Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB Phase 1
Completed NCT01072045 - Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma Phase 2